2024
The Influence of DNA Repair Genes and Prenatal Tobacco Exposure on Risk of Childhood Acute Lymphoblastic Leukemia: A Gene-Environment Interaction Study.
Wang X, Zhong C, Ma X, Metayer C, Mancuso N, Gauderman W, Wiemels J. The Influence of DNA Repair Genes and Prenatal Tobacco Exposure on Risk of Childhood Acute Lymphoblastic Leukemia: A Gene-Environment Interaction Study. Cancer Epidemiology Biomarkers & Prevention 2024, 34: 100-107. PMID: 39495115, PMCID: PMC11981794, DOI: 10.1158/1055-9965.epi-24-1037.Peer-Reviewed Original ResearchPrenatal tobacco exposureTobacco exposureGene-environment interaction studiesNon-Latino white childrenAcute lymphoblastic leukemia riskChildhood ALL riskRepair genesGene-environment interactionsAcute lymphoblastic leukemiaStatistically significant interactionPotential risk factorsDNA repair genesTobacco smokeLatino childrenPediatric oncologyALL riskTargeted preventionWhite childrenLogistic regressionEpidemiological studiesEnvironmental exposuresRisk factorsTobaccoGenotype dataSignificant interactionDefining the Denominator for Measuring Quality of End-of-Life Care in Children with Cancer: Results of a Nominal Group Technique
Johnston E, Tefera R, Ananth P, Martinez I, Porter A, Snaman J, Thienprayoon R, Asch S, Bhatia S, O'Beirne R. Defining the Denominator for Measuring Quality of End-of-Life Care in Children with Cancer: Results of a Nominal Group Technique. The Journal Of Pediatrics 2024, 271: 114038. PMID: 38554745, DOI: 10.1016/j.jpeds.2024.114038.Peer-Reviewed Original ResearchEnd-of-lifePoor-prognosis cancerEnd-of-life quality measuresQuality of EOL careQuality measuresPediatric oncologyPediatric palliative carePediatric quality measuresPrognosis cancersNon-Hispanic whitesNominal groupsSpecific treatment scenarioNominal group techniqueEOL carePalliative careSeventy-nine percentBereaved parentsMeasure qualityClinical programsEnhance qualityGroup techniqueGroup of childrenCareParticipantsClinician-scientists
2023
Defining the denominator for measuring quality of end-of-life care in children with cancer: Results of a nominal group technique.
Johnston E, Tefera R, Ananth P, Martinez I, Porter A, Snaman J, Thienprayoon R, Asch S, Bhatia S, O'Beirne R. Defining the denominator for measuring quality of end-of-life care in children with cancer: Results of a nominal group technique. JCO Oncology Practice 2023, 19: 227-227. DOI: 10.1200/op.2023.19.11_suppl.227.Peer-Reviewed Original ResearchEOL quality measuresPoor-prognosis cancerQuality of EOLSpecific treatment scenarioNominal group techniqueHigh-quality EOL carePediatric palliative carePediatric critical careQuality of endNon-Hispanic whitesNational Quality ForumClinical program developmentAdvanced diseasePalliative carePediatric oncologyEOL careCritical careLife careStage IIIHospice cliniciansCertain symptomsCancerQuality ForumLife quality measuresTreatment scenariosCritical elements of pediatric neuroblastoma surgery
Shaffiey S, Le H, Christison-Lagay E, Fialkowski E, Aldrink J, Grant C, Honeyman J, Janek K, Madonna M, Rhee D, Nuchtern J, Newman E, LaQuaglia M, Davidoff A, Shamberger R, Malek M. Critical elements of pediatric neuroblastoma surgery. Seminars In Pediatric Surgery 2023, 32: 151338. PMID: 38042090, DOI: 10.1016/j.sempedsurg.2023.151338.Peer-Reviewed Original ResearchConceptsHigh-risk neuroblastomaOncology GroupChildren's Oncology GroupPediatric surgical oncologyLong-term survivalNeuroblastoma surgeryExtracranial malignanciesEffective surgeryPediatric oncologyChildhood cancerSurgical oncologyNeuroblastomaSurgeryInternational SocietyOncologyExpert opinionLiterature reviewPatientsMalignancyCancerIncidenceImportant roleWhere Are the Children? A Thematic Analysis of State, Territory, and Tribal Organization Comprehensive Cancer Control Plans
Leraas H, Beckhorn C, Washabaugh C, Thamby J, Greenup R, Haines K, Allen L, Tracy E. Where Are the Children? A Thematic Analysis of State, Territory, and Tribal Organization Comprehensive Cancer Control Plans. Journal Of Pediatric Surgery 2023, 59: 129-133. PMID: 37858391, DOI: 10.1016/j.jpedsurg.2023.09.022.Peer-Reviewed Original ResearchConceptsComprehensive Cancer Control ProgramPediatric cancer careCancer careChildhood cancerEarly detectionPediatric cancer survivorshipComprehensive cancer control plansDistrict of ColumbiaCancer control programsCancer control plansAdult cancer riskU.S. territoriesTreatment disparitiesPediatric oncologyRisk factorsCancer preventionLevel IVCancer survivorshipCancer riskPediatric cancerChildhood exposureCancerCancer treatmentCareTribal organizationsPrognostic Communication Between Parents and Clinicians in Pediatric Oncology: An Integrative Review
Ouyang N, Feder S, Baker J, Knobf M. Prognostic Communication Between Parents and Clinicians in Pediatric Oncology: An Integrative Review. American Journal Of Hospice And Palliative Medicine® 2023, 41: 545-557. PMID: 37309610, DOI: 10.1177/10499091231183107.Peer-Reviewed Original ResearchHigh-quality longitudinal studiesPediatric oncologyPrognostic communicationIntegrative reviewLongitudinal studyNon-Hispanic whitesDecisional regretClinical practiceQualitative studyModerate qualityOncologyChild's diagnosisCliniciansParental distressMost parentsFirst yearDiagnosisInconsistent definitionsReviewDiverse populationsMost studies
2021
Distribution of the workforce involved in cancer care: a systematic review of the literature ☆
Trapani D, Murthy S, Boniol M, Booth C, Simensen V, Kasumba M, Giuliani R, Curigliano G, Ilbawi A. Distribution of the workforce involved in cancer care: a systematic review of the literature ☆. ESMO Open 2021, 6: 100292. PMID: 34763251, PMCID: PMC8591344, DOI: 10.1016/j.esmoop.2021.100292.Peer-Reviewed Original ResearchConceptsCancer careSystematic reviewHigh-income countriesHealth providersMultidisciplinary cancer careMultidisciplinary cancer managementSkilled health workforceCross-sectional surveyPaucity of dataHealth care workforcePaucity of literatureFirst systematic reviewCancer nursesCancer patientsPediatric oncologySurgical oncologyHealth workersWorkforce densityCancer managementEligible papersCancer workforceHealth workforceHealth systemCare workforceWorkforce capacityPerspectives of pediatric oncologists and palliative care physicians on the therapeutic use of cannabis in children with cancer
Oberoi S, Protudjer JLP, Rapoport A, Rassekh SR, Crooks B, Siden H, Decker K, Ananth P, Chapman S, Balneaves LG, Vanan MI, Kelly LE. Perspectives of pediatric oncologists and palliative care physicians on the therapeutic use of cannabis in children with cancer. Cancer Reports 2021, 5: e1551. PMID: 34672127, PMCID: PMC9458513, DOI: 10.1002/cnr2.1551.Peer-Reviewed Original ResearchConceptsPalliative care physiciansCare physiciansPediatric oncologistsCannabis-related researchPediatric oncology patientsManagement of nauseaMost pediatric oncologistsSafety of cannabisPotential roleUse of cannabisSymptom controlPoor appetiteSymptom reliefChronic painOncology patientsPediatric oncologySide effectsMedical cannabisOncologistsTherapeutic useAnticancer effectsPhysiciansCancerSurvey domainsCannabisTransfusion practices for pediatric oncology and hematopoietic stem cell transplantation patients: Data from the National Heart Lung and Blood Institute Recipient Epidemiology and Donor Evaluation Study‐III (REDS‐III)
Goel R, Nellis ME, Karam O, Hanson SJ, Tormey CA, Patel RM, Birch R, Sachais BS, Sola‐Visner M, Hauser RG, Luban NLC, Gottschall J, Josephson CD, Hendrickson JE, Karafin MS, Study‐IV‐Pediatric F. Transfusion practices for pediatric oncology and hematopoietic stem cell transplantation patients: Data from the National Heart Lung and Blood Institute Recipient Epidemiology and Donor Evaluation Study‐III (REDS‐III). Transfusion 2021, 61: 2589-2600. PMID: 34455598, DOI: 10.1111/trf.16626.Peer-Reviewed Original ResearchConceptsInternational normalized ratioBlood Institute Recipient EpidemiologyDonor Evaluation Study-IIINational Heart LungTransfusion practicePediatric oncologyRecipient EpidemiologyHSCT patientsPlasma transfusionRed blood cellsPlatelet countHeart LungHematopoietic stem cell transplantation patientsHematopoietic stem cell transplant patientsMedian international normalized ratioStem cell transplant patientsStem cell transplantation patientsLower INR valuesPre-transfusion HbMedian platelet countMulticenter retrospective studyCell transplant patientsCell transplantation patientsStudy IIIAcute myeloid leukemia
2020
SNMMI Procedure Standard/EANM Practice Guideline on Pediatric 18F-FDG PET/CT for Oncology 1.0
Vali R, Alessio A, Balza R, Borgwardt L, Bar-Sever Z, Czachowski M, Jehanno N, Kurch L, Pandit-Taskar N, Parisi M, Piccardo A, Seghers V, Shulkin B, Zucchetta P, Lim R. SNMMI Procedure Standard/EANM Practice Guideline on Pediatric 18F-FDG PET/CT for Oncology 1.0. Journal Of Nuclear Medicine 2020, 62: 99-110. PMID: 33334912, PMCID: PMC8679588, DOI: 10.2967/jnumed.120.254110.Peer-Reviewed Original ResearchConceptsEuropean Association of Nuclear MedicineF-FDG PET/CTF-FDGComputerized tomographyTechnology subsequent to publicationEvidence-based recommendationsLevel of trainingNuclear medicineLevel of evidenceDiagnostic nuclear medicine imagingPractice of medicineComplexity of human conditionsMedicine careStandard of careScience of nuclear medicineLegal standard of careCourse of actionMedicine practiceConsensus processPractice guidelinesSociety of Nuclear MedicinePediatric oncologyMedical professionalsClinician guidelinesApplications of nuclear medicineUsing a Collaborative, Virtual Discussion Platform to Mobilize Oncologic Expertise for the COVID-19 Pandemic.
Bejjani A, Burt L, Washington C, Terao M, Housri S, Housri N. Using a Collaborative, Virtual Discussion Platform to Mobilize Oncologic Expertise for the COVID-19 Pandemic. JCO Clinical Cancer Informatics 2020, 4: 794-798. PMID: 32897736, PMCID: PMC7529517, DOI: 10.1200/cci.20.00073.Peer-Reviewed Original ResearchConceptsGynecologic oncologyPediatric oncologyActive disease sitesCOVID-19 pandemicOncology patientsMedical oncologyClinical managementBreast cancerOncology expertsCare resourcesInitial experienceDisease sitesDisease typeOncologyWorldwide pandemicOncologistsRadiation oncologyHealth careCOVID-19Peer-reviewed informationSubstantial numberPandemicTotal numberPatientsCancer
2019
PET/MR Imaging: Current Updates on Pediatric Applications
Kwatra N, Lim R, Gee M, States L, Vossough A, Lee E. PET/MR Imaging: Current Updates on Pediatric Applications. Magnetic Resonance Imaging Clinics Of North America 2019, 27: 387-407. PMID: 30910104, DOI: 10.1016/j.mric.2019.01.012.Peer-Reviewed Original Research
2017
Medical marijuana in pediatric oncology: A review of the evidence and implications for practice
Ananth P, Reed‐Weston A, Wolfe J. Medical marijuana in pediatric oncology: A review of the evidence and implications for practice. Pediatric Blood & Cancer 2017, 65 PMID: 28926679, DOI: 10.1002/pbc.26826.Peer-Reviewed Original ResearchConceptsMedical marijuanaPediatric oncologyCancer-related symptomsPediatric oncology patientsSupportive care agentsMechanism of actionSupportive carePediatric patientsOncology patientsSerious illnessCare agentsPatientsOncologyMarijuanaPotential benefitsPurported benefitsFuture investigationsReviewSymptomsIllnessCancerCare
2012
Ethical Considerations in Pediatric Oncology: A Case‐Based Psychosocial Overview
Blum R, Martin A. Ethical Considerations in Pediatric Oncology: A Case‐Based Psychosocial Overview. 2012, 231-245. DOI: 10.1002/9781119941033.ch20.Peer-Reviewed Original Research
1991
Multidrug resistance in human neuroblastoma cells
LaQuaglia M, Kopp E, Spengler B, Meyers M, Biedler J. Multidrug resistance in human neuroblastoma cells. Journal Of Pediatric Surgery 1991, 26: 1107-1112. PMID: 1719182, DOI: 10.1016/0022-3468(91)90684-l.Peer-Reviewed Original ResearchMeSH KeywordsAntineoplastic AgentsATP Binding Cassette Transporter, Subfamily B, Member 1Cell LineColchicineDactinomycinDNA, NeoplasmDoxorubicinDrug ResistanceGene AmplificationHumansImmunoblottingMembrane GlycoproteinsNeoplasm ProteinsNeuroblastomaProto-Oncogene Proteins c-mycRNA, NeoplasmTumor Cells, CulturedVincristineConceptsHuman neuroblastoma cellsMultidrug-resistant phenotypeChemotherapeutic agentsNeuroblastoma cellsMultidrug resistanceProtein levelsN-myc amplificationHuman neuroblastoma SKDrug-resistant sublinesSteady-state messenger RNAConcentration of actinomycinPediatric oncologyN-myc protooncogeneP-glycoproteinNeuroblastoma SKWestern blottingRNA levelsC cellsDot blot analysisPossible alterationsGene amplificationSublinesMessenger RNANatural product drugsStepwise increase
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply